SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-246310
Filing Date
2019-09-17
Accepted
2019-09-17 08:45:32
Documents
1
Period of Report
2019-09-11
Items
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d805080d8k.htm 8-K 24976
  Complete submission text file 0001193125-19-246310.txt   26461
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38155 | Film No.: 191096050
SIC: 2834 Pharmaceutical Preparations